Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418529
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-05-13
Brief Title:
A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Comparative Effectiveness of New Initiators of Tofacitinib and Other BiologicTargeted Synthetic DMARDs in Patients With Rheumatoid Arthritis
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to learn how different types of medicines may improve disease activity in people with rheumatoid arthritis RA RA is a kind of joint disease that causes pain and swelling
The study will look at data from a large US-based group of RA patients who have taken the below medicines
Tofacitinib
Abatacept
Tocilizumab or sarilumab
The study will compare clinical disease activity scores of patients on the different medicines taken The study will also decide whether some patient traits or disease factors play a role in how medicines may improve disease activity
The study will look at data from a large US-based group of RA patients who have taken the below medicines
Tofacitinib
Abatacept
Tocilizumab or sarilumab
The study will compare clinical disease activity scores of patients on the different medicines taken The study will also decide whether some patient traits or disease factors play a role in how medicines may improve disease activity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None